Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent higher for adults 50 and older than a currently available shot. The shot also showed strong efficacy against each of the major influenza strains...
FDA commissioner stirs debate over hormone therapy for menopause
- today, 6:01 AM
- thehill.com
- 0
No comments